Coherus Pulls A Rabbit Out Of The Hat With Inventive Pegfilgrastim Form

Firm Guiding For Q2 Launch, On-Body Injector Set To Follow Later In 2023

 
• By Dean Rudge

Coherus’ year-end financial results included a surprise – a newly approved formulation of pegfilgrastim.

Business development idea and developing industry success through creative invention as a light bulb evolving to a gear shape as a 3D illustration.
• Source: Shutterstock

More from Products

More from Generics Bulletin